ATE325114T1 - Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung - Google Patents

Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung

Info

Publication number
ATE325114T1
ATE325114T1 AT00940768T AT00940768T ATE325114T1 AT E325114 T1 ATE325114 T1 AT E325114T1 AT 00940768 T AT00940768 T AT 00940768T AT 00940768 T AT00940768 T AT 00940768T AT E325114 T1 ATE325114 T1 AT E325114T1
Authority
AT
Austria
Prior art keywords
optionally substituted
group
hydrogen
hydrocarbon group
hydrocarbyl
Prior art date
Application number
AT00940768T
Other languages
English (en)
Inventor
Fumio Itoh
Hiroshi Hosono
Masaki Kawamura
Keiji Kubo
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE325114T1 publication Critical patent/ATE325114T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
AT00940768T 1999-06-22 2000-06-21 Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung ATE325114T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP17605799 1999-06-22
JP26628099 1999-09-20
JP2000017956 2000-01-24

Publications (1)

Publication Number Publication Date
ATE325114T1 true ATE325114T1 (de) 2006-06-15

Family

ID=27324198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00940768T ATE325114T1 (de) 1999-06-22 2000-06-21 Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung

Country Status (7)

Country Link
US (1) US6723722B1 (de)
EP (1) EP1188755B1 (de)
AT (1) ATE325114T1 (de)
AU (1) AU5566300A (de)
CA (1) CA2383492A1 (de)
DE (1) DE60027718T2 (de)
WO (1) WO2000078747A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002006234A1 (en) * 2000-07-17 2002-01-24 Takeda Chemical Industries, Ltd. Sulfone derivatives, process for their production and use thereof
ATE315561T1 (de) * 2000-11-08 2006-02-15 Takeda Pharmaceutical Carbamatderivate, verfahren zu deren herstellung und deren verwendung
WO2003078389A1 (en) * 2002-03-15 2003-09-25 Kissei Pharmaceutical Co., Ltd. Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative
CA2483573A1 (en) 2002-05-03 2003-11-13 Elan Pharmaceuticals, Inc. Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
WO2004035579A1 (ja) * 2002-10-15 2004-04-29 Takeda Pharmaceutical Company Limited イミダゾピリジン誘導体、その製造法および用途
AU2003284596A1 (en) * 2002-11-22 2004-06-18 Takeda Pharmaceutical Company Limited Imidazole derivative, process for producing the same, and use
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
LT3305776T (lt) 2004-05-14 2020-01-10 Vertex Pharmaceuticals Incorporated Pirolo junginiai kaip erk baltymo kinazės inhibitoriai, ir farmacinės kompozicijos su šiais junginiais
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
RU2318818C1 (ru) * 2006-04-12 2008-03-10 Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124610A (en) * 1964-03-10 Preparation of intermediates
US3067237A (en) * 1959-04-14 1962-12-04 Sterling Drug Inc Lower-alkyl mono-or bis-(alkanesulfonamido) benzoate esters
GB992961A (en) * 1960-07-28 1965-05-26 Ciba Ltd Process for the manufacture of amino acid derivatives
US3441570A (en) * 1966-01-20 1969-04-29 Parke Davis & Co 3-tertiary aminoalkylamino-3-phenyl oxindole compounds
JPS5216156B2 (de) * 1972-08-16 1977-05-07
DE2602422A1 (de) * 1976-01-23 1977-07-28 Thomae Gmbh Dr K Neue 6-aminopenicillansaeuren, ihre salze und derivate und verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP0126849A1 (de) * 1983-02-18 1984-12-05 The Wellcome Foundation Limited Pharmakologisch aktive N-Aminohydantoin-Derivate, Verfahren zu deren Herstellung und deren Zwischenprodukte
JPH07119982B2 (ja) * 1986-04-18 1995-12-20 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
GB8704158D0 (en) * 1987-02-23 1987-04-01 Wellcome Found Substituted hydantoin compounds
JPH0782221B2 (ja) * 1988-06-28 1995-09-06 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
GB9011589D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Amino bicyclic compounds
US5182272A (en) * 1991-05-03 1993-01-26 G. D. Searle & Co. 8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides, pharmaceutical compositions, and methods for treating pain
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE4228717A1 (de) 1992-08-28 1994-03-03 Cassella Ag Imidazolidin-Derivate
TW394760B (en) 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
US5612353A (en) 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
JPH10161270A (ja) * 1996-10-01 1998-06-19 Fuji Photo Film Co Ltd 熱現像記録材料
UA56197C2 (uk) 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
AR012374A1 (es) * 1997-04-15 2000-10-18 Smithkline Beecham Corp Inhibidores de proteasas, composiones farmaceuticas y usos para la preparacion de medicamentos.
ATE334975T1 (de) * 1997-05-30 2006-08-15 Takeda Pharmaceutical Sulfonamidderivate, ihre herstellung und verwendung
JP3830060B2 (ja) * 1997-06-09 2006-10-04 富士写真フイルム株式会社 熱現像記録材料
DE19728524A1 (de) * 1997-07-04 1999-01-07 Merck Patent Gmbh Cyclische Azapeptide
GB9715892D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
JPH11119373A (ja) * 1997-10-14 1999-04-30 Fuji Photo Film Co Ltd 熱現像記録材料
JPH11133545A (ja) * 1997-10-31 1999-05-21 Fuji Photo Film Co Ltd 熱現像記録材料
CA2318351A1 (en) 1997-12-26 1999-07-08 Hidemitsu Nishida Aromatic compounds having cyclic amino or salts thereof
TR200002182T2 (tr) 1998-01-27 2000-12-21 Aventis Pharmaceuticals Products Inc. İkame edilmiş aksozaherosayklil faktör xa inhibitörleri
WO1999040075A1 (en) 1998-02-05 1999-08-12 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, process for producing the same and utilization thereof
JPH11327077A (ja) * 1998-05-11 1999-11-26 Fuji Photo Film Co Ltd 熱現像記録材料
US6239151B1 (en) * 1998-06-26 2001-05-29 Hoffmann-La Roche Inc. Compounds as inhibitor of tumor necrosis factor alpha release

Also Published As

Publication number Publication date
EP1188755B1 (de) 2006-05-03
US6723722B1 (en) 2004-04-20
WO2000078747A1 (en) 2000-12-28
WO2000078747A8 (en) 2001-03-29
AU5566300A (en) 2001-01-09
EP1188755A1 (de) 2002-03-20
DE60027718T2 (de) 2007-05-16
CA2383492A1 (en) 2000-12-28
EP1188755A4 (de) 2003-01-08
DE60027718D1 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
NO953305D0 (no) Antranilsyrederivat
ATE368655T1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
WO2000047580A3 (en) Phenyl urea and phenyl thiourea derivatives
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
PT1178967E (pt) Derivados de quinolina como inibidores de enzimas mek
DK0452873T3 (da) 1,8-naphthyridin-2-on-derivater
DE3677452D1 (de) Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE124695T1 (de) Kondensierte heterocyclische verbindungen, ihre herstellung und verwendung.
ATE325114T1 (de) Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE69929669D1 (de) Zyklische Amidderivate die Cathepsin K hemmen
DE60140748D1 (de) Thiazol-derivate zur verwendung als entzündungshemmende mittel
ATE183739T1 (de) N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie
DE68905407D1 (de) Analgetische carbonsaeureamid-derivate.
ATE146479T1 (de) Modifizierte oligodeoxyribonukleotide, ihre herstellung und ihre therapeutische verwendung
ATE118770T1 (de) Thiazolidinone und oxazolidenonederivate, ihre herstellung und ihre anwendung als vasodilatatoren.
ATE168376T1 (de) Triazolopyridazin-derivate, ihre herstellung und verwendung
ATE145908T1 (de) 5-triazolo(3,4-i)purinderivate
EP1219605A4 (de) Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung
DE60014936D1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
ATE384717T1 (de) Stereoisomere indolderivate, verfahren zu ihrer herstellung und ihre verwendung
ES2159693T3 (es) Ligandos 5ht1dalfa y 5ht2a.
DE60019619D1 (de) Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel
ATE137748T1 (de) Antimagengeschwür pyridyloxyderivate, verfahren zu deren herstellung und ihre verwendung
EP1340753A4 (de) Carbamatderivate, verfahren zu deren herstellung und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties